MedPath

Perceived Stress and Black Rice (Oryza Sativa L.) Extract Fermented With Lactobacillus

Not Applicable
Completed
Conditions
Perceived Stress
Registration Number
NCT06091033
Lead Sponsor
Pusan National University Yangsan Hospital
Brief Summary

The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects and tolerability of black rice (Oryza Sativa L.) extract fermented with Lactobacillus on patients with perceived stress for 8 weeks.

Detailed Description

A previous animal study has indicated that black rice (Oryza Sativa L.) extract fermented with Lactobacillus relieved stressful situations in a 7-week-old C57BL/6 mice model. Therefore, the investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects and tolerability of black rice (Oryza Sativa L.) extract fermented with Lactobacillus on patients with perceived stress for 8 weeks; the safety of the compound is also evaluated. The Investigators examine stress response inventory (SRI), perceived stress scale (PSS), stress-visual analog scale (VAS), EQ-5D-5L, salivary cortisol, plasma cortisol, serotonin, dehydroepiandrosterone sulfate (DHEAS), cortisol/DHEAS ratio, adrenocorticotropic hormone (ACTH), glucose, lactate, free fatty acid (FFA), malondialdehyde (MDA) superoxide dismutase (SOD), heart rate, systolic blood pressure (BP), and diastolic BP at baseline and after 8 weeks of intervention. Eighty adults were administered either 1,000 mg of black rice (Oryza Sativa L.) extract fermented with Lactobacillus or a placebo each day for 8 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • the Perceived Stress Scale between 13-18
Exclusion Criteria
  • People with alcohol use/induced disorders
  • Persons with brain disease or undergoing rehabilitation treatment for brain disease
  • Patients with mental illnesses such as major affective disorder, post-traumatic stress disorder, uncontrolled obsessive-compulsive disorder, schizophrenia, dementia, drug addiction, etc.
  • Those who have taken psychotropic drugs, sleeping pills, appetite suppressants, oral steroids, and corticosteroids within 1 month before starting the trial
  • Those who have taken functional health foods recognized by the Ministry of Food and Drug Safety related to relieving tension caused by stress and improving sleep within 1 month before the start of the test
  • Those who show withdrawal symptoms due to abstinence from drinking or smoking within 1 month before starting the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
stress response inventory (SRI)8 weeks

using SRI score. The minimum score was 0, and the maximum score was 195; higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Salivary cortisol (ng/dl)8 weeks

Change during 8 weeks

Plasma serotonin (nmol/L)8 weeks

Change during 8 weeks

Plasma cortisol/dehydroepiandrosterone sulfate ratio8 weeks

Change during 8 weeks

Plasma adrenocorticotropic hormone (pg/mL)8 weeks

Change during 8 weeks

Fasting glucose (mg/dL)8 weeks

Change during 8 weeks

perceived stress scale (PSS)8 weeks

using PSS score. The minimum score was 0, and the maximum score was 40; higher scores mean a worse outcome.

stress-Visual Analog Scale (VAS)8 weeks

using stress-VAS score. The minimum score was 0, and the maximum score was 100; higher scores mean a worse outcome.

EuroQol (EQ)-5D-5L8 weeks

using stress-VAS score. The minimum score was 0, and the maximum score was 1; higher scores mean a worse outcome.

Plasma cortisol (ng/dl)8 weeks

Change during 8 weeks

Plasma dehydroepiandrosterone sulfate (µg/dL)8 weeks

Change during 8 weeks

Lactate (mmol/L)8 weeks

Change during 8 weeks

Free fatty acid (µmol/L)8 weeks

Change during 8 weeks

Heart rate (beats per minute)8 weeks

Change during 8 weeks

Systolic blood pressure (BP) (mmHg)8 weeks

Change during 8 weeks

Diastolic BP(mmHg)8 weeks

Change during 8 weeks

Trial Locations

Locations (1)

Pusan National University Yangsan Hospital

🇰🇷

Yangsan, Gyeungsangnam-do, Korea, Republic of

Pusan National University Yangsan Hospital
🇰🇷Yangsan, Gyeungsangnam-do, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.